patients
Levels of fibrinopeptide A (FPA), thrombin-antithrombin       complexes (TAT), and prothrombin fragment 1.2 (F1.2) were not lower in patients       treated with eptifibatide than in the control group.
Levels of fibrinopeptide A (FPA), thrombin-antithrombin       complexes (TAT), and  @OBJECT$  (F1.2) were not lower  @PREDICAT$   @SUBJECT$        treated with eptifibatide than in the control group.